Open Date
-
Close Date
-
Listing Date
-
Price Range
₹0.0 to ₹0.0
IPO Size
₹0.00 Cr
Exchange Symbols
Asston Pharmaceuticals Ltd
Cutoff - Lot Size
Open Date
Close Date
Listing Date
Price Range
IPO Size
Exchange Symbols
Open Date
Close Date
Listing Date
Price Range
IPO Size
Exchange Symbols
Formulation Expertise.
Experienced Promoters.
Wide range of Products.
Strategic Location.
Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African and Asian markets. Presently our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion), and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. As on the date of this Draft Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis. Our Company basically gives contract for manufacturing the products to WHO-GMP certified contract manufacturers and FDA-accredited laboratories, ensuring adherence to industry standards from production to export. From manufacturing to exports and distributions, our Company takes responsibility and oversees each phase of the supply chain.
Company Name | Asston Pharmaceuticals Ltd |
Headquarter | Mumbai |
info@asstonpharmaceuticals.com | |
Website | www.asstonpharmaceuticals.com |
Maashitla Securities Pvt Ltd
Phone Number | 011-45121795 |
Email ID | ipo@maashitla.com |
Website | www.maashitla.com |
Initial public issue of up to 22,41,600 equity shares of face value of Rs.10/- each (the "Equity Shares") of Asston Pharmaceuticals Limited ("the Company" or "APL" or "the Issuer") at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores ("Public Isue") out of which upto 1,12,800 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute [*] % and [*] %, respectively of the post-issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
Address: 4th Flr Office No.A-431 Balaji, Bhavan Plot No.42A Sec-11 CBD, Mumbai, Maharashtra, 400614
Phone: +91 22 4973 1411/+91 22 4973 1419
Email: info@asstonpharmaceuticals.com
Website: www.asstonpharmaceuticals.com
Open Date: -
Close Date: -
Issue Price: ₹
Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.
Congratulations,
Your Digital savings bank account opening journey is complete.